Cepheid molecular diagnostic testing system reagents and assays - VISN 6 IDIQ
Ended Awarded Last action
- Contract number
- 36C24626N0116
- Awardee
-
Cepheid UEI W6HQTMWB9Q28
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $299,404
Award facts
- Opportunity
-
- 6550--Cepheid Molecular Diagnostic Testing System Reagents and Assays - VISN 6 BPA Special Notice · Posted Nov 13, 2024
- Contract value 100% obligated
- $299,404.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Sunnyvale, CA 94089, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $299,404 |
About this award
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $299,404 by Veterans Integrated Service Network 6 (VISN 6) for Cepheid Molecular Diagnostic Testing System Reagents and Assays. This firm fixed-price delivery order, issued on October 1, 2025, is expected to be completed by September 30, 2026, and operates under the larger VISN 6 Indefinite Delivery Contract valued at $32.8 million through September 2030. The contract carries no set-aside designation and supports the Department of Veterans Affairs' clinical laboratory operations through the provision of molecular diagnostic testing supplies and reagents for the GeneXpert diagnostic platform. Cepheid serves as the established prime contractor, with the Department of Veterans Affairs as the funding civilian agency.
This delivery order represents part of Cepheid's extensive federal contracting portfolio as a primary supplier of advanced molecular diagnostic systems and reagents to multiple federal healthcare agencies. The company specializes in rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and methicillin-resistant Staphylococcus aureus through its GeneXpert platform. Cepheid's established relationships across the VA healthcare system—spanning numerous VISNs and medical centers—demonstrate the company's critical role in supporting diagnostic capabilities across the federal healthcare network. The firm fixed-price structure and consistent award patterns reflect Cepheid's competitive positioning in federal molecular diagnostics procurement.
Quick answers
Who was awarded contract 36C24626N0116?
36C24626N0116 was awarded to Cepheid by Veterans Integrated Service Network 6 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C24626N0116 worth?
The government has obligated $299,404 on 36C24626N0116.
Is contract 36C24626N0116 an order under another contract?
Yes. 36C24626N0116 is a delivery order under 36C24626D0001, an indefinite delivery contract.
Was contract 36C24626N0116 competed?
The extent of competition for 36C24626N0116 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award